Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Emerging risks | Growth Opportunities | APAC Insurance

Wednesday, July 2, 2025
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Emerging risks | Growth opportunities | APAC insurance

Wednesday, 2 July 2025
Linkedin
Newsletter
Free trial
Subscribe
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Dedicated hubs

Life and Health
LifeandHealth_Menuwebp
Cyber
Cyber_Menuwebp
Energy
EnergyMenuwebp
Marine
MarineMenuwebp
Regulation
RegulationMenuwebp
Capital management
CapitalMenu
Nat cat
NatCatMenu

Browse content

Report: China Life invests US $42.4m in Series B round for Yingke Biopharmaceutic

Yingke was established in 2022 and is engaged in the R&D of pharmaceutical drugs
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Editorial team

THIS PREMIUM INSIGHT IS FOR SUBSCRIBERS ONLY.

Stay ahead with precise, independent journalism of APAC's insurance markets.

Unlocked access today:

Already subscribed? Log in using the form below or click here

Share this article

Read next

cyber-premiums-crash-in-australia-as-motor-claims-continue-to-soar
global-brokers-maintain-appetite-for-apac-acquisitions-despite-2024-mampa-slowdown
globaldata-hong-kong-life-insurance-market-to-grow-by-2-9-in-2025
health-motor-lines-sustain-indias-gi-growth-in-may
globaldata-australias-general-insurance-sector-set-for-second-consecutive-year-of-slowing-growth
Has IFRS 17 delivered on its promises in APAC
Investments weaker yen cushion JGB losses as Japanese life insurers push ahead with overseas growth
singapore-insurance-carriers-sees-strong-first-quarter-growth-led-by-engineering-health-and-motor-lines
hualien-earthquake-spotlights-semiconductor-coverage-gap
rising-healthcare-costs-forcing-asias-insurers-to-withdraw-rethink-strategy
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

© Playfair Media 2024

17/F, 80 Gloucester Road, Wan Chai, Hong Kong